Global Trachea, Bronchus or Lung Malignant Neoplasms Mortality by Country

The global mortality from trachea, bronchus, or lung malignant neoplasms reveals significant disparities among countries. In 2023, the United States topped the list with the highest deaths, experiencing a slight decrease compared to the previous year. Japan showed a modest increase, while Germany, the UK, and Poland all posted minor declines. Conversely, countries like South Korea and Finland observed notable increases. Over the past five years, trends have varied, suggesting that environmental, healthcare infrastructure, and policy factors play critical roles. Looking forward, trends suggest increased mortality in countries with rising urbanization and air pollution unless mitigated by healthcare advancements and policy interventions.

Future trends to watch include the impact of improved healthcare policies, lifestyle changes, and technological advancements that could potentially reverse upward mortality trends in specific regions, particularly focusing on rising air quality concerns and early detection measures.

Top countries in Trachea, Bronchus or Lung Malignant Neoplasms Mortality by Country

# 10 Countries Units (Deaths) Last Year YoY 5-years CAGR
1 1 United States 126,830 2023 -2.38% -2.26% View data
2 2 Japan 76,890 2023 +0.56% +0.68% View data
3 3 Germany 44,300 2023 -0.36% -0.26% View data
4 4 United Kingdom 32,300 2023 -1.47% -1.37% View data
5 5 Brazil 29,890 2023 +1.37% +0.82% View data
6 6 Poland 21,930 2023 -0.5% -1.56% View data
7 7 Canada 20,160 2023 +0.38% +0.22% View data
8 8 South Korea 19,900 2023 +2% +2.2% View data
9 9 Netherlands 9,840 2023 -1.04% -1.06% View data
10 10 Argentina 8,960 2023 +0.45% -0.56% View data

Top Countries about Lung Cancer